Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 25 entries
Sorted by: Best Match Show Resources per page
Single-dose antibiotic prophylaxis during cesarean section.

Primary care update for Ob/Gyns

Gugino L, Cimino M, Wactawski-Wende J.
PMID: 10838270
Prim Care Update Ob Gyns. 1998 Jul 01;5(4):147-148. doi: 10.1016/s1068-607x(98)00025-0.

Objective: To compare single-dose antibiotic prophylaxis (cefotetan 1 g vs cefoxitin 2 g) in various subpopulations based upon risk factors for postsurgical infection following cesarean section.Methods: Patients undergoing cesarean section from April 1993 through March 1994 were included in...

Cite
Gugino L, Cimino M, Wactawski-Wende J. Single-dose antibiotic prophylaxis during cesarean section. Prim Care Update Ob Gyns. 1998;5(4):147-148doi: 10.1016/s1068-607x(98)00025-0.
Gugino, L., Cimino, M., & Wactawski-Wende, J. (1998). Single-dose antibiotic prophylaxis during cesarean section. Primary care update for Ob/Gyns, 5(4), 147-148. https://doi.org/10.1016/s1068-607x(98)00025-0
Gugino, et al. "Single-dose antibiotic prophylaxis during cesarean section." Primary care update for Ob/Gyns vol. 5,4 (1998): 147-148. doi: https://doi.org/10.1016/s1068-607x(98)00025-0
Gugino L, Cimino M, Wactawski-Wende J. Single-dose antibiotic prophylaxis during cesarean section. Prim Care Update Ob Gyns. 1998 Jul 01;5(4):147-148. doi: 10.1016/s1068-607x(98)00025-0. PMID: 10838270.
Copy Download .nbib Format: NLM
Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.

Texas Heart Institute journal

Bosso JA, Prince RA.
PMID: 15227388
Tex Heart Inst J. 1990;17(2):77-85.

No abstract available.

Cite
Bosso JA, Prince RA. Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole. Tex Heart Inst J. 1990;17(2):77-85
Bosso, J. A., & Prince, R. A. (1990). Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole. Texas Heart Institute journal, 17(2), 77-85.
Bosso, J A, and Prince, R A. "Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole." Texas Heart Institute journal vol. 17,2 (1990): 77-85.
Bosso JA, Prince RA. Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole. Tex Heart Inst J. 1990;17(2):77-85. PMID: 15227388; PMCID: PMC326456.
Copy Download .nbib Format: NLM
Gender differences in the microbial spectrum and antibiotic sensitivity of uropathogens isolated from patients with urinary stones.

Journal of clinical laboratory analysis

Gu J, Chen X, Yang Z, Bai Y, Zhang X.
PMID: 34854120
J Clin Lab Anal. 2021 Dec 02;e24155. doi: 10.1002/jcla.24155. Epub 2021 Dec 02.

PURPOSE: The characteristics and resistance patterns of urine bacteriology urolithiasis patients between male and female have not been extensively studied. This study aims to investigate the gender differences in microbial spectrum and antibiotic susceptibility of uropathogens isolated from urolithiasis...

Cite
Gu J, Chen X, Yang Z, et al. Gender differences in the microbial spectrum and antibiotic sensitivity of uropathogens isolated from patients with urinary stones. J Clin Lab Anal. 2021;e24155doi: 10.1002/jcla.24155.
Gu, J., Chen, X., Yang, Z., Bai, Y., & Zhang, X. (2021). Gender differences in the microbial spectrum and antibiotic sensitivity of uropathogens isolated from patients with urinary stones. Journal of clinical laboratory analysis, e24155. https://doi.org/10.1002/jcla.24155
Gu, Jie, et al. "Gender differences in the microbial spectrum and antibiotic sensitivity of uropathogens isolated from patients with urinary stones." Journal of clinical laboratory analysis vol. (2021): e24155. doi: https://doi.org/10.1002/jcla.24155
Gu J, Chen X, Yang Z, Bai Y, Zhang X. Gender differences in the microbial spectrum and antibiotic sensitivity of uropathogens isolated from patients with urinary stones. J Clin Lab Anal. 2021 Dec 02;e24155. doi: 10.1002/jcla.24155. Epub 2021 Dec 02. PMID: 34854120.
Copy Download .nbib Format: NLM
Virtual screening of inhibitors against Envelope glycoprotein of Chikungunya Virus: a drug repositioning approach.

Bioinformation

Agarwal G, Gupta S, Gabrani R, Gupta A, Chaudhary VK, Gupta V.
PMID: 31312082
Bioinformation. 2019 Jun 15;15(6):439-447. doi: 10.6026/97320630015439. eCollection 2019.

Chikungunya virus (CHIKV) a re-emerging mosquito-borne alpha virus causes significant distress which is further accentuated in the lack of specific therapeutics or a preventive vaccine, mandating accelerated research for anti-CHIKV therapeutics. In recent years, drug repositioning has gained recognition...

Cite
Agarwal G, Gupta S, Gabrani R, et al. Virtual screening of inhibitors against Envelope glycoprotein of Chikungunya Virus: a drug repositioning approach. Bioinformation. 2019;15(6):439-447doi: 10.6026/97320630015439.
Agarwal, G., Gupta, S., Gabrani, R., Gupta, A., Chaudhary, V. K., & Gupta, V. (2019). Virtual screening of inhibitors against Envelope glycoprotein of Chikungunya Virus: a drug repositioning approach. Bioinformation, 15(6), 439-447. https://doi.org/10.6026/97320630015439
Agarwal, Garima, et al. "Virtual screening of inhibitors against Envelope glycoprotein of Chikungunya Virus: a drug repositioning approach." Bioinformation vol. 15,6 (2019): 439-447. doi: https://doi.org/10.6026/97320630015439
Agarwal G, Gupta S, Gabrani R, Gupta A, Chaudhary VK, Gupta V. Virtual screening of inhibitors against Envelope glycoprotein of Chikungunya Virus: a drug repositioning approach. Bioinformation. 2019 Jun 15;15(6):439-447. doi: 10.6026/97320630015439. eCollection 2019. PMID: 31312082; PMCID: PMC6614119.
Copy Download .nbib Format: NLM
Outpatient parenteral antibiotic therapy.

International journal of antimicrobial agents

Poretz DM.
PMID: 18611638
Int J Antimicrob Agents. 1995 Jan;5(1):9-12. doi: 10.1016/0924-8579(94)00041-r.

Clinical studies have shown that outpatient administration of parenteral antibiotics is sage, cost-effective and practical. The development of new antibiotics with prolonged half-lives, such as ceftriaxone or cefotetan, has facilitated outpatient parenteral antibiotic therapy (OPAT). Good OPAT management requires...

Cite
Poretz DM. Outpatient parenteral antibiotic therapy. Int J Antimicrob Agents. 1995;5(1):9-12doi: 10.1016/0924-8579(94)00041-r.
Poretz, D. M. (1995). Outpatient parenteral antibiotic therapy. International journal of antimicrobial agents, 5(1), 9-12. https://doi.org/10.1016/0924-8579(94)00041-r
Poretz, D M. "Outpatient parenteral antibiotic therapy." International journal of antimicrobial agents vol. 5,1 (1995): 9-12. doi: https://doi.org/10.1016/0924-8579(94)00041-r
Poretz DM. Outpatient parenteral antibiotic therapy. Int J Antimicrob Agents. 1995 Jan;5(1):9-12. doi: 10.1016/0924-8579(94)00041-r. PMID: 18611638.
Copy Download .nbib Format: NLM
Fatal drug-induced immune hemolytic anemia due to cefotetan; A case study.

Asian journal of transfusion science

Perkins J.
PMID: 20041074
Asian J Transfus Sci. 2008 Jan;2(1):20-3. doi: 10.4103/0973-6247.39507.

A case is described here of drug-induced immune hemolytic anemia (DIIHA) due to cefotetan administered to a post-partum woman who received the drug for infection prophylaxis at the time of caesarean section. Renewed fatal hemolysis occurred when the drug...

Cite
Perkins J. Fatal drug-induced immune hemolytic anemia due to cefotetan; A case study. Asian J Transfus Sci. 2008;2(1):20-3doi: 10.4103/0973-6247.39507.
Perkins, J. (2008). Fatal drug-induced immune hemolytic anemia due to cefotetan; A case study. Asian journal of transfusion science, 2(1), 20-3. https://doi.org/10.4103/0973-6247.39507
Perkins, Jim. "Fatal drug-induced immune hemolytic anemia due to cefotetan; A case study." Asian journal of transfusion science vol. 2,1 (2008): 20-3. doi: https://doi.org/10.4103/0973-6247.39507
Perkins J. Fatal drug-induced immune hemolytic anemia due to cefotetan; A case study. Asian J Transfus Sci. 2008 Jan;2(1):20-3. doi: 10.4103/0973-6247.39507. PMID: 20041074; PMCID: PMC2798759.
Copy Download .nbib Format: NLM
Comparison of short vs. Long half-life single-dose prophylactic antibiotics for cesarean section.

Infectious diseases in obstetrics and gynecology

Gonik B, McGregor J.
PMID: 18475377
Infect Dis Obstet Gynecol. 1994;2(3):120-5. doi: 10.1155/S1064744994000505.

OBJECTIVE: Numerous studies demonstrate the efficacy of antibiotic prophylaxis for reducing postcesarean section infectious morbidity. The duration of therapy, however, remains controversial. Cost containment measures and the ease of single dosing have led to the introduction of "extended" half-life...

Cite
Gonik B, McGregor J. Comparison of short vs. Long half-life single-dose prophylactic antibiotics for cesarean section. Infect Dis Obstet Gynecol. 1994;2(3):120-5doi: 10.1155/S1064744994000505.
Gonik, B., & McGregor, J. (1994). Comparison of short vs. Long half-life single-dose prophylactic antibiotics for cesarean section. Infectious diseases in obstetrics and gynecology, 2(3), 120-5. https://doi.org/10.1155/S1064744994000505
Gonik, B, and McGregor, J. "Comparison of short vs. Long half-life single-dose prophylactic antibiotics for cesarean section." Infectious diseases in obstetrics and gynecology vol. 2,3 (1994): 120-5. doi: https://doi.org/10.1155/S1064744994000505
Gonik B, McGregor J. Comparison of short vs. Long half-life single-dose prophylactic antibiotics for cesarean section. Infect Dis Obstet Gynecol. 1994;2(3):120-5. doi: 10.1155/S1064744994000505. PMID: 18475377; PMCID: PMC2364371.
Copy Download .nbib Format: NLM
Immunologic evaluation of patients with cefotetan-induced anaphylaxis.

Allergy, asthma & immunology research

Nam YH, Hwang EK, Ban GY, Jin HJ, Yoo HS, Shin YS, Ye YM, Nahm DH, Park HS, Lee SK.
PMID: 25749763
Allergy Asthma Immunol Res. 2015 May;7(3):301-3. doi: 10.4168/aair.2015.7.3.301. Epub 2014 Oct 08.

Cefotetan is a commonly prescribed second-generation cephalosporin that acts against a wide range of bacteria. However, cefotetan-induced hypersensitivity has rarely been reported. We report 2 cases of cefotetan-induced anaphylaxis with immunologic evaluation. The first case was a 70-year-old asthmatic...

Cite
Nam YH, Hwang EK, Ban GY, et al. Immunologic evaluation of patients with cefotetan-induced anaphylaxis. Allergy Asthma Immunol Res. 2014;7(3):301-3doi: 10.4168/aair.2015.7.3.301.
Nam, Y. H., Hwang, E. K., Ban, G. Y., Jin, H. J., Yoo, H. S., Shin, Y. S., Ye, Y. M., Nahm, D. H., Park, H. S., & Lee, S. K. (2015). Immunologic evaluation of patients with cefotetan-induced anaphylaxis. Allergy, asthma & immunology research, 7(3), 301-3. https://doi.org/10.4168/aair.2015.7.3.301
Nam, Young Hee, et al. "Immunologic evaluation of patients with cefotetan-induced anaphylaxis." Allergy, asthma & immunology research vol. 7,3 (2015): 301-3. doi: https://doi.org/10.4168/aair.2015.7.3.301
Nam YH, Hwang EK, Ban GY, Jin HJ, Yoo HS, Shin YS, Ye YM, Nahm DH, Park HS, Lee SK. Immunologic evaluation of patients with cefotetan-induced anaphylaxis. Allergy Asthma Immunol Res. 2015 May;7(3):301-3. doi: 10.4168/aair.2015.7.3.301. Epub 2014 Oct 08. PMID: 25749763; PMCID: PMC4397372.
Copy Download .nbib Format: NLM
Emergence of .

Infection and drug resistance

Patil S, Chen H, Guo C, Zhang X, Ren PG, Francisco NM, Wen F.
PMID: 34511949
Infect Drug Resist. 2021 Sep 02;14:3581-3588. doi: 10.2147/IDR.S324018. eCollection 2021.

AIM: We investigated the clonal diversity of carbapenemase-producing METHODS: From January 2014 to December 2018, a total number of 36 unique carbapenemase-producing clinical isolates of RESULTS: The isolates showed resistance to ceftazidime, ertapenem, ampicillin, cefazolin, ceftriaxone, cefotetan, ticarcillin, cefaclor,...

Cite
Patil S, Chen H, Guo C, et al. Emergence of . Infect Drug Resist. 2021;14:3581-3588doi: 10.2147/IDR.S324018.
Patil, S., Chen, H., Guo, C., Zhang, X., Ren, P. G., Francisco, N. M., & Wen, F. (2021). Emergence of . Infection and drug resistance, 143581-3588. https://doi.org/10.2147/IDR.S324018
Patil, Sandip, et al. "Emergence of ." Infection and drug resistance vol. 14 (2021): 3581-3588. doi: https://doi.org/10.2147/IDR.S324018
Patil S, Chen H, Guo C, Zhang X, Ren PG, Francisco NM, Wen F. Emergence of . Infect Drug Resist. 2021 Sep 02;14:3581-3588. doi: 10.2147/IDR.S324018. eCollection 2021. PMID: 34511949; PMCID: PMC8422287.
Copy Download .nbib Format: NLM
Drug-Induced Immune Hemolytic Anemia Caused by Postoperative Cefotetan Administration.

Annals of dermatology

Park S, Song S, Baek J, Park H.
PMID: 34341644
Ann Dermatol. 2021 Aug;33(4):384-386. doi: 10.5021/ad.2021.33.4.384. Epub 2021 Jul 01.

No abstract available.

Cite
Park S, Song S, Baek J, et al. Drug-Induced Immune Hemolytic Anemia Caused by Postoperative Cefotetan Administration. Ann Dermatol. 2021;33(4):384-386doi: 10.5021/ad.2021.33.4.384.
Park, S., Song, S., Baek, J., & Park, H. (2021). Drug-Induced Immune Hemolytic Anemia Caused by Postoperative Cefotetan Administration. Annals of dermatology, 33(4), 384-386. https://doi.org/10.5021/ad.2021.33.4.384
Park, Seha, et al. "Drug-Induced Immune Hemolytic Anemia Caused by Postoperative Cefotetan Administration." Annals of dermatology vol. 33,4 (2021): 384-386. doi: https://doi.org/10.5021/ad.2021.33.4.384
Park S, Song S, Baek J, Park H. Drug-Induced Immune Hemolytic Anemia Caused by Postoperative Cefotetan Administration. Ann Dermatol. 2021 Aug;33(4):384-386. doi: 10.5021/ad.2021.33.4.384. Epub 2021 Jul 01. PMID: 34341644; PMCID: PMC8273326.
Copy Download .nbib Format: NLM
Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly.

Pharmaceuticals (Basel, Switzerland)

Sipos M, Farcas A, Leucuta DC, Bucsa C, Huruba M, Mogosan C.
PMID: 34067178
Pharmaceuticals (Basel). 2021 May 07;14(5). doi: 10.3390/ph14050441.

BACKGROUND: The objective of this study was to characterize individual case safety reports (ICSRs) and adverse drug reactions (ADRs) related to second-generation cephalosporins and resulting in hepatobiliary disorders, in VigiBase, WHO global database.METHODS: All second-generation cephalosporins hepatobiliary ADRs reported...

Cite
Sipos M, Farcas A, Leucuta DC, et al. Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly. Pharmaceuticals (Basel). 2021;14(5)doi: 10.3390/ph14050441.
Sipos, M., Farcas, A., Leucuta, D. C., Bucsa, C., Huruba, M., & Mogosan, C. (2021). Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly. Pharmaceuticals (Basel, Switzerland), 14(5), . https://doi.org/10.3390/ph14050441
Sipos, Mariana, et al. "Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly." Pharmaceuticals (Basel, Switzerland) vol. 14,5 (2021). doi: https://doi.org/10.3390/ph14050441
Sipos M, Farcas A, Leucuta DC, Bucsa C, Huruba M, Mogosan C. Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly. Pharmaceuticals (Basel). 2021 May 07;14(5). doi: 10.3390/ph14050441. PMID: 34067178; PMCID: PMC8151124.
Copy Download .nbib Format: NLM
Bacteriologic and therapeutic considerations in intra-abdominal surgical infections.

Anaerobe

Giamarellou H, Kanellakopoulou K.
PMID: 16887592
Anaerobe. 1997 Apr-Jun;3(2):207-12. doi: 10.1006/anae.1997.0107.

The most important factor in the treatment of intra-abdominal infections are early diagnosis and prompt surgical intervention while antibiotics play a secondary role. The goals of surgical procedures should be to stop peritoneal contamination, to debride necrotic tissue, to...

Cite
Giamarellou H, Kanellakopoulou K. Bacteriologic and therapeutic considerations in intra-abdominal surgical infections. Anaerobe. 1997;3(2):207-12doi: 10.1006/anae.1997.0107.
Giamarellou, H., & Kanellakopoulou, K. (1997). Bacteriologic and therapeutic considerations in intra-abdominal surgical infections. Anaerobe, 3(2), 207-12. https://doi.org/10.1006/anae.1997.0107
Giamarellou, H, and Kanellakopoulou, K. "Bacteriologic and therapeutic considerations in intra-abdominal surgical infections." Anaerobe vol. 3,2 (1997): 207-12. doi: https://doi.org/10.1006/anae.1997.0107
Giamarellou H, Kanellakopoulou K. Bacteriologic and therapeutic considerations in intra-abdominal surgical infections. Anaerobe. 1997 Apr-Jun;3(2):207-12. doi: 10.1006/anae.1997.0107. PMID: 16887592.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 25 entries